Driven by multiple factors such as an increasing number of patients, growing unmet clinical needs, increased investment in innovative drug research and development, and favorable government policies, the global and Chinese markets for innovative drugs have developed vigorously. The compound growth rates from 2016 to 2020 were 3.0% and 2.2%, respectively. The pharmaceutical market can be divided into anti-tumor drugs and other drugs. The global and Chinese markets for anti-tumor drugs have continued to grow rapidly, with annual compound growth rates of 12.5% and 12.1%, respectively, from 2016 to 2020. The number of innovative drugs developed by biopharmaceutical companies has increased, and diversification of research and development models is gradually becoming a new trend in the market. (This report was issued on September 3, 2021)
The above content is only an abstract of the report. If you need to read more, please contact us. Thank you!
